Bioventus ( Bioventus)

Primary tabs

Bioventus's picture

Management

Contact Address

About Bioventus

Our mission is to help sufferers of fractures or osteoarthritic pain heal more effectively in less invasive ways. To this end, we develop and/or market clinically proven and cost-effective orthopaedic therapies and diagnostic tools, including osteoarthritis pain treatments, bone fracture healing systems, and biologic bone growth factor technology. We create bone healing therapies that work to enhance the body’s natural healing process, thereby accelerating recovery and improving the patient’s quality of life. Our injection therapies that treat osteoarthritic joints relieve pain and help bring mobility back to the patient. Our therapies may also reduce the need for invasive procedures, leading to more cost-effective outcomes than previously possible.

Bioventus press release, blog etc

Wed, 10/12/2022 - 09:55 Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
Tue, 07/12/2022 - 04:48 Bioventus Completes CartiHeal Acquisition
Mon, 04/04/2022 - 04:01 Bioventus Exercises Call Option to Acquire CartiHeal
Mon, 12/20/2021 - 23:16 Bioventus Appoints Michelle McMurry-Heath to Board of Directors
Sun, 12/19/2021 - 21:44 Bioventus Receives US FDA Clearance for BoneScalpel Access
Thu, 11/18/2021 - 18:17 Bioventus to Expand Operations and Manufacturing in Memphis
Mon, 11/15/2021 - 18:19 Bioventus Announces Chief Financial Officer Transition Plan
Mon, 11/01/2021 - 18:34 Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs
Fri, 10/29/2021 - 18:17 Bioventus Completes the Acquisition of Misonix
Mon, 10/25/2021 - 20:39 Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus
Mon, 08/30/2021 - 15:51 Bioventus Proceeds with Option Structure Agreement with CartiHeal
Tue, 08/24/2021 - 21:54 Bioventus Invests in Trice Medical Minimally Invasive Technologies Bioventus Also Agrees to OUS Distribution and Co-Development Relationships
Mon, 08/23/2021 - 04:40 Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer
Tue, 07/27/2021 - 05:49 Bioventus Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference
Wed, 07/14/2021 - 05:31 Bioventus Appoints Mary Kay Ladone to Board of Directors
Tue, 07/13/2021 - 04:28 Bioventus Launches OSTEOAMP SELECT Flowable Nationwide
Thu, 06/24/2021 - 05:38 Bioventus Invests in Vaporox
Tue, 05/25/2021 - 03:38 Bioventus Study Shows Novel Placental Tissue Biologic Candidate Inhibited Inflammatory and Catabolic Responses In Vitro